Low-Glycemic (LGI) Diet in Pregnant People With Epilepsy
NCT06175247 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2023-12-18
Summary
The goal of this clinical trial is to learn about the low glycemic index diet in pregnant people with epilepsy. The main questions it aims to answer are:
* Is the low glycemic index tolerable in pregnant people with epilepsy?
* Does the low glycemic index alter seizure frequency in pregnant people with epilepsy?
* Does the low glycemic index alter the gut bacteria \& associated metabolic pathways in pregnant people with epilepsy? Participants will start the low glycemic index diet during pregnancy and will provide stool and blood samples a maximum of 3 times during study duration. Researchers will compare pregnant people with epilepsy on the diet to pregnant people with epilepsy not on a structured diet plan to see if tolerability, seizure frequency, and gut bacteria composition \& metabolites differ.
Conditions
Interventions
- OTHER
-
Low Glycemic Index Diet
A low glycemic diet will be initiated with dietician support and guidance.
Sponsors & Collaborators
-
Epilepsy Foundation
collaborator OTHER -
Brigham and Women's Hospital
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-12-15
- Primary Completion
- 2025-11-01
- Completion
- 2025-11-01
Countries
- United States
Study Locations
More Related Trials
-
Epigenetics and Gut Microbiota in Children With Epilepsy
NCT04063007 ·Status: UNKNOWN ·Phase: NA
-
Intermittent Fasting in Refractory Epilepsy
NCT02311023 ·Status: TERMINATED ·Phase: PHASE2
-
Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy
NCT00280059 ·Status: COMPLETED ·Phase: PHASE3
-
IF-MCT 16:8: Investigating the Influence of Intermittent Fasting With and Without MCTs in Patients With Drug-resistant Epilepsy
NCT06013761 ·Status: COMPLETED ·Phase: NA
-
Energy Expenditure and Quality of Life in Epilepsy
NCT04546711 ·Status: WITHDRAWN
-
Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy
NCT05605301 ·Status: COMPLETED ·Phase: PHASE2
-
The Modified Ketogenic Diet for the Treatment of Pharmacoresistant Epilepsy in Adults
NCT03425110 ·Status: UNKNOWN
-
Dose-Optimization, Adjunctive Treatment Study of Ezogabine/Retigabine Immediate Release in Partial-onset Seizures
NCT01721317 ·Status: TERMINATED ·Phase: PHASE4
-
An Open Label Study to Evaluate the Effects of Ezogabine/Retigabine Added to Existing Anti-epileptic Drug(s) on Urinary Voiding Function in Subjects With Partial Onset Seizures
NCT01607346 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluate the Efficacy of BGG492 as Adjunctive Treatment in Patients With Refractory Partial Onset Seizures
NCT01167335 ·Status: WITHDRAWN ·Phase: PHASE2
-
GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
NCT00567424 ·Status: WITHDRAWN ·Phase: PHASE2
-
Premenstrual Dysphoric Disorder and Antiepileptic Drugs
NCT00612235 ·Status: COMPLETED
-
Women With Epilepsy: Pregnancy Outcomes and Deliveries
NCT01259310 ·Status: COMPLETED
-
Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies
NCT05364021 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery
NCT00887861 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Retigabine Immediate Release as Adjunctive Therapy to Specified Monotherapy Antiepileptic Treatments in Adults With Partial-Onset Seizures
NCT01227902 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Effectiveness of the Outpatient Classical Ketogenic Diet and Modified Atkins Diet on Seizures Frequency, Nutritional Status and Some Biochemical Factors in Children and Adolescents With Intractable Epilepsy
NCT03014752 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Intermediate-Size Expanded Access Protocol (EAP) for LP352
NCT06149663 ·Status: AVAILABLE
-
Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome
NCT02834793 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent.
NCT03031028 ·Status: UNKNOWN ·Phase: PHASE2
-
MiCrobiota-gut-brain Axis in Resistant Epilepsy
NCT07010445 ·Status: RECRUITING ·Phase: NA
-
Evaluation of the 24/7 EEG™ SubQ System in Subjects With Uncontrolled Genetic Generalised Epilepsy Syndrome
NCT05241678 ·Status: COMPLETED
-
Study in Pediatric Subjects With Epilepsy
NCT01494584 ·Status: TERMINATED ·Phase: PHASE2
-
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
NCT05219617 ·Status: RECRUITING ·Phase: PHASE3
-
Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo
NCT00351611 ·Status: COMPLETED ·Phase: PHASE4